ClinicalTrials.gov - Information on Clinical Trials and Human Research Studies: Browse: Ureteral Neoplasms


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Browse : By Condition : By Disease Heading : Rare Diseases : Ureteral Neoplasms

Include trials that are no longer recruiting patients.

15 studies were found.
1. Recruiting TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced, Unresectable Transitional Cell Carcinoma (TCC) of the Urothelium
Conditions: Bladder Neoplasms; Ureteral Neoplasms; Urethral Neoplasms; Carcinoma, Transitional Cell
2. Recruiting FR901228 in Treating Patients With Advanced Cancer of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
3. Recruiting Short-Term Low-Dose Interferon alfa in Treating Patients With Cancer of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
4. Recruiting Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium
Conditions: stage III bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; anterior urethral cancer; posterior urethral cancer; ...
5. Recruiting Bortezomib in Treating Patients With Advanced Transitional Cell Carcinoma of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
6. Recruiting Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
7. Recruiting Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
Conditions: recurrent bladder cancer; stage IV bladder cancer; metastatic transitional cell cancer of the renal pelvis and ureter; ...
8. Recruiting Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
9. Recruiting Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
10. Recruiting Combination Chemotherapy Followed By Observation or Surgery in Treating Patients With Stage II or Stage III Cancer of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
11. Recruiting Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
12. Recruiting Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
13. Recruiting Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
14. Recruiting Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium
Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
15. Recruiting Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer
Conditions: stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ...

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services

1.	Recruiting	TOCOSOL(TM) Paclitaxel in Metastatic or Locally Advanced, Unresectable Transitional Cell Carcinoma (TCC) of the Urothelium Conditions: Bladder Neoplasms; Ureteral Neoplasms; Urethral Neoplasms; Carcinoma, Transitional Cell
2.	Recruiting	FR901228 in Treating Patients With Advanced Cancer of the Urothelium Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
3.	Recruiting	Short-Term Low-Dose Interferon alfa in Treating Patients With Cancer of the Urothelium Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
4.	Recruiting	Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium Conditions: stage III bladder cancer; regional transitional cell cancer of the renal pelvis and ureter; anterior urethral cancer; posterior urethral cancer; ...
5.	Recruiting	Bortezomib in Treating Patients With Advanced Transitional Cell Carcinoma of the Urothelium Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
6.	Recruiting	Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
7.	Recruiting	Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter Conditions: recurrent bladder cancer; stage IV bladder cancer; metastatic transitional cell cancer of the renal pelvis and ureter; ...
8.	Recruiting	Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
9.	Recruiting	Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
10.	Recruiting	Combination Chemotherapy Followed By Observation or Surgery in Treating Patients With Stage II or Stage III Cancer of the Urothelium Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
11.	Recruiting	Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
12.	Recruiting	Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
13.	Recruiting	Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
14.	Recruiting	Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
15.	Recruiting	Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer Conditions: stage III bladder cancer; stage IV bladder cancer; transitional cell carcinoma of the bladder; ...